Doctor profile · Federal record
Dr. Jawad Zafar, M.D.
Student in an Organized Health Care Education/Training Program (CMS: Family Practice) · Minneapolis, MN
- NPI 1629430905
- Accepts Medicare
- MIPS 81.7 / 100 · 2023
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
701 Park Ave
Minneapolis, MN 554151623
(612) 873-3000
Credentials & registration
- NPI registered
- March 2016 — 10 yrs on file
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 390200000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1629430905. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
688
Distinct HCPCS
5
Medicare allowed
$63,388
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 439 | 170 | $83 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 100 | 48 | $125 | |
99239 |
Hospital discharge day management, more than 30 minutes | 92 | 91 | $120 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 39 | 26 | $52 | |
99238 |
Hospital discharge day management, 30 minutes or less | 18 | 18 | $85 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 55. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$432
Transactions
6
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 3 | $142.90 | |
| Janssen Pharmaceuticals, Inc | 1 | $135.37 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $124.99 | |
| Alkermes, Inc. | 1 | $28.55 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
455
Patients
340
Total drug cost
$65,972
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 54 | 51 | $555 |
| Brilinta (Ticagrelor) | Brand | 50 | 24 | $23,905 |
| Eliquis (Apixaban) | Brand | 45 | 24 | $28,254 |
| Atorvastatin Calcium | Generic | 42 | 33 | $358 |
| Spironolactone | Generic | 38 | 33 | $224 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 32 | 17 | $517 |
| Furosemide | Generic | 31 | 29 | $108 |
| Torsemide | Generic | 28 | 23 | $463 |
| Losartan Potassium | Generic | 25 | 25 | $171 |
| Amiodarone Hcl | Generic | 21 | 14 | $782 |
Frequently asked questions
What is Dr. Jawad Zafar's medical specialty?
Dr. Jawad Zafar practices Student in an Organized Health Care Education/Training Program in Minneapolis, MN.
Where does Dr. Jawad Zafar practice?
Dr. Jawad Zafar practices at 701 Park Ave, Minneapolis, MN 554151623. Office phone: 6128733000.
What is Dr. Jawad Zafar's NPI?
Dr. Jawad Zafar's National Provider Identifier (NPI) is 1629430905, issued by NPPES.
Does Dr. Jawad Zafar accept Medicare assignment?
Yes. Dr. Jawad Zafar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jawad Zafar commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Hospital discharge day management (HCPCS 99239). Source: CMS Medicare Physician & Other Practitioners file.